Epidermolysis bullosa stem cell therapy (Holostem Terapie Avanzate)

N/A

Report date: 2022/12/06 20:44:35

Base Information

Drug NameEpidermolysis bullosa stem cell therapy (Holostem Terapie Avanzate)
Drug Alias NameHologene-17
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesParacelsus Medical UniversityHolostem Terapie Avanzate Srl
China Registration ClassN/A

Develop Information

Active CompaniesHolostem Terapie Avanzate SrlParacelsus Medical University
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A